Description

Lamizil Spray 1% 30 ml

Ingredients:

Each 1% spray contains Terbinafine Hydrochloride as the active ingredient.

Mechanism of Action:

Terbinafine Hydrochloride, the active ingredient in Lamizil Spray, inhibits the enzyme squalene epoxidase in fungi, leading to a decrease in ergosterol synthesis and disruption of fungal cell membrane function.

Pharmacological Properties:

Lamizil Spray exhibits potent antifungal activity against a wide range of dermatophytes and yeasts.

Indications for Use:

Lamizil Spray is indicated for the treatment of athlete’s foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) caused by susceptible fungal infections.

Contraindications:

Avoid using Lamizil Spray if you have a known hypersensitivity to Terbinafine or any other components of the formulation.

Side Effects:

• Common side effects may include skin irritation, itching, or a burning sensation at the application site.
• Severe allergic reactions are rare but seek medical attention if you experience symptoms like rash, swelling, or difficulty breathing.

Usage Instructions:

For adults and children over 12 years, apply a thin layer of Lamizil Spray to the affected area twice daily for one week. Ensure the skin is clean and dry before application. Wash hands after use.

Benefits Compared to Analogues:

Lamizil Spray stands out due to its high efficacy in treating fungal skin infections with a convenient twice-daily application regimen, leading to rapid symptom relief and improved patient compliance compared to other antifungal agents.

Suitable Patient Groups:

Lamizil Spray is suitable for use in adults, adolescents, and children over 12 years of age. Consult a healthcare provider for appropriate guidance in special populations such as pregnant or breastfeeding individuals.

Storage and Shelf Life:

Store Lamizil Spray at room temperature away from direct sunlight and heat sources. Check the expiration date on the packaging and do not use the product if past the indicated shelf life.

Packaging Description:

Lamizil Spray is available in a 30 ml container with a nozzle for easy application. The packaging is designed to maintain product integrity and ensure accurate dosage delivery.

Scientific Evidence:

Lamizil Spray has demonstrated significant efficacy in clinical trials. Studies published in reputable journals like the Journal of the American Academy of Dermatology have highlighted the rapid and sustained antifungal effects of Terbinafine, supporting the use of Lamizil Spray in the management of fungal skin infections.

Additional Information:

Patient adherence to the prescribed treatment regimen is crucial for successful outcomes. It is essential to complete the full course of Lamizil Spray even if symptoms improve to prevent recurrence of the infection. Prior consultation with a healthcare professional is recommended for individuals with specific medical conditions or during pregnancy and lactation.